The collaborative research conducted by the Division of Nuclear Medicine and the Division of Cardiology explores the innovative application of artificial intelligence (AI) to enhance the detection of cardiac amyloidosis using bone scintigraphy scans.
Cardiac amyloidosis is a progressive heart disease that frequently leads to heart failure if not diagnosed early. Spielvogel's research focuses on developing AI-supported image analysis methods that run parallel to conventional visual readings by nuclear medicine physicians, potentially allowing for more reliable and earlier detection of this severe condition.
Spielvogel's work exemplifies the transformative potential of integrating AI with traditional medical imaging techniques. By improving the accuracy and timeliness of cardiac amyloidosis detection, his research holds promise for significantly better patient outcomes.
About Clemens Spielvogel
Clemens Spielvogel, Ph.D., obtained his doctorate in computational medical imaging from the Medical University of Vienna in 2023. He also holds degrees in bioinformatics and biomedicine from the University of Applied Sciences Vienna and the University of Veterinary Medicine Vienna, respectively. Spielvogel has contributed to multiple high-profile peer-reviewed publications, including those in The Lancet Digital Health. His research interests primarily focus on the application of AI in nuclear medicine and the integration of imaging and non-imaging biomarkers.
For more information about Clemens Spielvogel and his research, visit his researcher profile.
Link to the Society of Nuclear Medicine and Molecular Imaging (SNMMI)